Command Palette

Search for a command to run...

KIMS

716.85-1.36%

Market Cap
₹28,699.97 Cr
Stock P/E
76.23
ROCE
19.04%
ROE
20.92%
Book Value
₹55.55

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Foreign Investors
Domestic Investors
Public

From Last Concall

POSITIVES
  • Robust revenue growth driven by YoY expansion
  • Visible momentum from new units, including Thane
NEGATIVES
  • Near-term EBITDA losses from new units
  • Insurance empanelment delays leading to patient leakage

Peers Summary

Sector Leader

Krishna Institute of Medical Sciences Ltd (KIMS) shows robust growth metrics and decent profitability compared to its peers in the Hospital & Healthcare Services sector. While it faces high valuation pressures, its revenue and EPS growth stand out, signaling potential for future performance. Conversely, companies like Fortis Healthcare Ltd are significantly overvalued, indicating a risk for investors. Aster DM Healthcare Ltd appears financially weak with low profitability and high debt levels, marking it as a risky investment choice.

Key Points
  • KIMS demonstrates strong revenue growth and profitability metrics among peers.
  • Aster DM Healthcare shows the lowest valuation metrics and weakest financial performance.
  • Apollo Hospitals and Max Healthcare are noted for their profitability but have higher valuation ratios.
Top Performers
Krishna Institute of Medical Sciences Ltd

Strong revenue growth of 21.49% YoY and solid EPS growth of 9.6092.

Apollo Hospitals Enterprise Ltd.

High ROE (20.51%) and competitive PE ratio (85.15) showing solid profitability.

Narayana Hrudayalaya Ltd.

Highest ROE (24.27%) and good EPS growth (38.66) with reasonable valuation.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.